Shares of Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) shot up 11.1% during mid-day trading on Tuesday . The stock traded as high as GBX 3.68 and last traded at GBX 3.50. 20,624,805 shares changed hands during trading, an increase of 1,413% from the average session volume of 1,363,058 shares. The stock had previously closed at GBX 3.15.
Cizzle Biotechnology Stock Performance
The firm has a market capitalization of £14.87 million, a P/E ratio of -20.59 and a beta of 0.07. The firm’s 50-day moving average is GBX 2.71 and its 200 day moving average is GBX 2.01.
Cizzle Biotechnology (LON:CIZ – Get Free Report) last posted its quarterly earnings data on Tuesday, May 5th. The company reported GBX (0.17) earnings per share (EPS) for the quarter.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
Further Reading
- Five stocks we like better than Cizzle Biotechnology
- 5 High-Yield Stocks With Analyst Support and Room to Run
- AST SpaceMobile Announces Launch Date for Its Next 3 BlueBird Satellites
- Is Lennar Finally Turning the Corner After Its Housing Slump?
- AI Memory Demand Has Turned These 5 S&P 500 Stocks Into Market Leaders
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
